Biosecure Act to face House vote amid security concerns

Efforts to end US business deals with certain foreign biotechs considered threats are gaining traction again, with House Speaker Mike Johnson stating his intention to hold a vote on the BIOSECURE act this year.

The bill targets specific biotech and genomics firms with alleged connections to the Chinese government and military, aiming to block federal contracts with these companies due to potential national security risks.

The US House Committee on Oversight and Accountability endorsed the BIOSECURE Act in May, with members voting in favor by 40-1. Despite this, the bill has since been delayed in its legislative progress.